Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN68,2368,261,12
Msft0,59
Nokia3,25253,49750,52
IBM0,53
Mercedes-Benz Group AG68,2668,29-0,23
PFE-0,60
11.05.2024 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 10.05.2024 21:59:46
Cardinal Health (CAH, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
99,54 1,51 1,48 1 252 632
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 11.05.2024
Popis společnosti
Obecné informace
Název společnostiCardinal Health Inc
TickerCAH
Kmenové akcie:Ordinary Shares
RICCAH
ISIN-
Poslední známé roční výsledky30.06.2023
Poslední známé čtvrtletní výsledky31.03.2024
Počet zaměstnanců k 30.06.2023 48 000
Akcie v oběhu k 26.04.2024 243 566 952
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice7000 Cardinal Pl
MěstoDUBLIN
PSČ43017
ZeměUnited States
Kontatní osobaMatt Sims
Funkce kontaktní osobyVice President - Investor Relations
Telefon16 147 573 033
Fax16147576000

Business Summary: Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products and laboratory product solutions. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. The Company's segments include Pharmaceutical and Medical. Its Pharmaceutical segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States. Its Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets.
Financial Summary: BRIEF: For the nine months ended 31 March 2024, Cardinal Health Inc revenues increased 10% to $167.12B. Net income increased 90% to $616M. Revenues reflect Pharmaceutical segment increase of 11% to $155.18B, United States segment increase of 10% to $163.51B, International segment increase of 6% to $3.63B. Net income benefited from Medical segment income increase from $29M to $162M, Pharmaceutical segment income increase of 7% to $1.61B.
Odvětvová klasifikace
TRBC2009Retail - Drugs
TRBC2012Pharmaceuticals Wholesale
RBSS2004Retail - Drugs
MGINDUSTRYMajor Drugs
MGSECTORHealthcare
NAICSDrugs and Druggists' Sundries Merchant Wholesalers
NAICSPharmaceutical Preparation Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICSSurgical Appliance and Supplies Manufacturing
NAICS2007Drugs and Druggists' Sundries Merchant Wholesalers
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Surgical Appliance & Supplies Mfg
NAICS1997Drug, Drug Proprietaries and Druggists' Sundries Wholesalers
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Surgical Appliance and Supplies Manufacturing
SICDrugs/proprietaries/sundries
SICDrugs/proprietaries/sundries
SICPharmaceutical Preparations
SICSurgical And Medical Instruments
SICSurgical Appliances And Supplies



  • Poslední aktualizace: 11.05.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, DirectorJason Hollar5001.09.202226.05.2020
Chief Financial OfficerAaron Alt5210.02.202310.02.2023
Chief Executive Officer - Medical SegmentStephen Mason5216.08.201916.08.2019
Chief Executive Officer of Pharmaceutical SegmentDeborah Weitzman-19.09.202319.09.2023
Chief Human Resource OfficerOla Snow-
Chief Legal and Compliance OfficerJessica Mayer54